Hims & Hers Health (HIMS) Common Equity (2019 - 2026)
Hims & Hers Health (HIMS) posted Common Equity of $446.2 million for Q1 2026, down 17.52% sequentially from $540.9 million in Q4 2025, and down 18.77% YoY from $549.3 million in Q1 2025.
Hims & Hers Health (HIMS) Common Equity (2019 - 2026) Analysis & Trends
Hims & Hers Health has reported Common Equity for 8 years, with the latest figure at $446.2 million in Q1 2026.
- Quarterly Common Equity fell 18.77% year-over-year to $446.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $446.2 million (down 18.77% YoY) and the FY2025 annual result came in at $540.9 million, up 13.47% from the prior year.
- Common Equity slipped to $446.2 million in Q1 2026 per HIMS's latest filing, from $540.9 million in the prior quarter.
- Over five years, Common Equity peaked at $581.0 million in Q3 2025 and troughed at $310.9 million in Q3 2022.
- A 5-year average of $404.6 million and a median of $344.5 million in 2024 frame the typical range for Common Equity.
- The sharpest annual moves came in 2025 and 2026: Common Equity soared 59.45% in 2025, then slipped 18.77% in 2026.
- Over 5 years, Common Equity stood at $311.7 million in 2022, then climbed by 10.36% to $344.0 million in 2023, then jumped by 38.57% to $476.7 million in 2024, then advanced by 13.47% to $540.9 million in 2025, then slipped by 17.52% to $446.2 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $446.2 million, $540.9 million, and $581.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 4.05 Bn |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn | 324.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 324.07 Mn |
| Mar 31, 2026 | 446.17 Mn |
| Dec 31, 2025 | 540.93 Mn |
| Sep 30, 2025 | 580.98 Mn |
| Jun 30, 2025 | 562.70 Mn |
| Mar 31, 2025 | 549.26 Mn |
| Dec 31, 2024 | 476.72 Mn |
| Sep 30, 2024 | 440.05 Mn |
| Jun 30, 2024 | 361.97 Mn |
| Mar 31, 2024 | 344.48 Mn |
| Dec 31, 2023 | 344.03 Mn |
| Sep 30, 2023 | 328.56 Mn |
| Jun 30, 2023 | 320.07 Mn |
| Mar 31, 2023 | 312.75 Mn |
| Dec 31, 2022 | 311.74 Mn |
| Sep 30, 2022 | 310.95 Mn |
| Jun 30, 2022 | 319.06 Mn |
| Mar 31, 2022 | 327.72 Mn |
| Dec 31, 2021 | 334.62 Mn |
| Sep 30, 2021 | 355.15 Mn |